Medical Ad Scientiam Launches International Study to Assess Disability Progression in Multiple Sclerosis With MSCopilotBy Marie JonesSeptember 12, 2023 Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter,…